Previous Expert Speaker Faculty

Take a look at the esteemed speaker faculty who attended the 8th RAS-Targeted Drug Development Summit.

Ivana

Ivana Sullivan

Medical Director, Clinical Research
Amgen Inc.
Luke Pase

Luke Pase

Chief Technology Officer
Anocca AB
Stephanie Greenstein Braun

Stephanie Braun

Executive Director & Head of Enzalutamide, Medical Affairs (US)
Astellas Pharma
Wonil Kim

Wonil Kim

Chief Scientific Officer
Aston Sci
Federico Innocenti Speaker - 8th RAS-Targeted Drug Development Summit

Federico Innocenti

Senior Director, Clinical Development - Solid Tumors
BeOne Medicines
Michael Sweeney

Michael Sweeney

Director, Alliance Management, Business Development Operations
Biodesix
Geoff

Geoff Oxnard

Chief Medical Officer & Executive VP
BlossomHill Therapeutics
Sai Vikram Vemula

Sai Vemula

Associate Director, Translational Medicine, Immuno Oncology
Bristol Myers Squibb
Mani

Mani Mohindru

President, Chief Executive Officer & Member of the Board
Cardiff Oncology
Zhan Yao

Zhan Yao

Executive Director, Discovery Signaling
Eli Lilly & Co.
Pete DeMuth

Peter DeMuth

Chief Scientific Officer
Elicio Therapeutics
Chad Pecot Speaker - 8th RAS-Targeted Drug Development Summit

Chad Pecot

Founder & Chief Scientific Officer
EnFuego Therapeutics
Jeffrey Kutok Speaker - 8th RAS-Targeted Drug Development Summit

Jeffery Kutok

Chief Scientific Officer
Ensem Therapeutics
Nagi Ayad Speaker - 8th RAS-Targeted Drug Development Summit

Nagi Ayad

Professor
Georgetown University
Andreas Varkaris Speaker - 8th RAS-Targeted Drug Development Summit

Andreas varkaris

MD
Harvard Medical School
Yizhe Wu Speaker - 8th RAS-Targeted Drug Development Summit

Yizhe Wu

Head of Drug Discovery
HealZen Therapeutics Co., Ltd.

Joseph Combs


Praveen Nair

Praveen Nair

VP
Immuneering Corp.
Matthew

Matthew Farren

Senior Research, Pharmacology Investigator
Incyte Corporation
Andrea Wang Gillam

Andrea Wang Gillam

Chief Medical Officer
Jacobio Pharmaceuticals Inc
George Fromm Speaker - 8th RAS-Targeted Drug Development Summit

George Fromm

Chief Scientific Officer
KAYAK
Tony Tran Speaker - 8th RAS-Targeted Drug Development Summit

Tony Tran

Director, Clinical Scientist
Kura Oncology

Simon Jiang


Andrew Stephen Speaker - 8th RAS-Targeted Drug Development Summit

Andrew Stephen

Team Lead, Biochemistry & Biophysics Research Team
NCI, RAS Initiative
Jeffrey Rothman Speaker - 8th RAS-Targeted Drug Development Summit

Jeffrey Rothman

Founding Chief Science Officer
Oncogenuity Inc.
Brent Meadows

Brent Meadows

Chief Business Officer
Polymed Biopharmaceuticals
Myles Walsh Speaker - 8th RAS-Targeted Drug Development Summit

Myles Walsh

Executive Director, Business Development
Predicine
Helena Kiefel

Helena Kiefel

Senior Director, Translational Research
Revolution Medicines
Mitchell Speaker - 8th RAS-Targeted Drug Development Summit

Mitchell Shirvan

Chief Scientific and Development Officer
Silexion Therapeutics

Ash Williams


Craig Ramirez

Craig Ramirez

Co-Founder & Chief Executive Officer
Tezcat Biosciences
Silvia

Silvia Coma

Senior Director, Translational & Preclinical Research
Verastem. inc
Jonathan Pachter - 8th RAS-Targeted Drug Development Summit

Jonathan Pachter

Chief Scientific Officer
Verastem. inc
Michael Hamilton Speaker - 8th RAS-Targeted Drug Development Summit

Michael Hamilton

Scientist II
Vividion Therapeutics
conference
Explore the Agenda

Hear the latest industry breakthroughs and gain exclusive insights during our packed agenda, interactive roundtables, and panel discussions.

View Previous Presentations & Speakers
summit
Partner With Us

Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma deals.

Explore Sponsorship Options
conference
Join Biopharma Experts

Be part of the hottest conversations with like-minded attendees spanning all stages of drug development and make critical connections during our dedicated networking sessions.

Register Interest